1. Home
  2. ADAMZ vs SCLXW Comparison

ADAMZ vs SCLXW Comparison

Compare ADAMZ & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ADAMZ

Adamas Trust Inc. 7.000% Series G Cumulative Redeemable Preferred Stock $0.01 par value per share

N/A

Current Price

$18.33

Market Cap

0.0

Sector

Real Estate

ML Signal

N/A

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

N/A

Current Price

$0.14

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ADAMZ
SCLXW
Founded
N/A
N/A
Country
United States
United States
Employees
221
34
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ADAMZ
SCLXW
Price
$18.33
$0.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.7K
5.3K
Earning Date
N/A
03-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$55,152,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.02
52 Week Low
$17.25
$0.05
52 Week High
$21.72
$0.64

Technical Indicators

Market Signals
Indicator
ADAMZ
SCLXW
Relative Strength Index (RSI) 47.71 46.87
Support Level $18.22 $0.11
Resistance Level $19.06 $0.18
Average True Range (ATR) 0.21 0.02
MACD -0.00 -0.01
Stochastic Oscillator 56.25 60.12

Price Performance

Historical Comparison
ADAMZ
SCLXW

About ADAMZ Adamas Trust Inc. 7.000% Series G Cumulative Redeemable Preferred Stock $0.01 par value per share

Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: